The Genome Sequencing Centers for Infectious Diseases (GSCID), funded by the National Institute of Allergy and Infectious Diseases (NIAID), are accepting applications for sequencing and genotyping projects. The three NIAID-sponsored Genome Sequencing Centers for Infectious Diseases are accepting applications for sequencing and genotyping projects. Investigators are invited to propose projects by submitting white papers. Eligibility criteria and other related information is available at URL above. The centers provide the infectious disease research community with rapid and cost-effective, high-quality sequencing services for pathogenic microorganisms, as well as invertebrate vectors. In addition, the centers can conduct genotyping studies of microbes and their human hosts in order to study the variation in host response. The centers also offer expertise in pathogen biology with the ultimate goal to use the sequencing and genotyping data to develop new diagnostics, vaccines, and drugs. The contract will continue for another four years at the centers located at the Broad Institute (Cambridge, MA), the J. Craig Venter Institute (Rockville, MD) and the Institute for Genome Sciences at the University of Maryland School of Medicine (Baltimore, MD).